Literature DB >> 6977383

Decreased actin content of lymphocytes from patients with chronic lymphocytic leukemia.

R Stark, L F Liebes, D Nevrla, M Conklyn, R Silber.   

Abstract

Actin, a major cytoskeletal protein, was quantitated in normal and chronic lymphocytic leukemia lymphocytes. The actin content of normal human blood lymphocytes was 2.2 +/- 0.4 mg/10(9) cells and represented 6.6% +/- 1.8% of the total cellular protein. A significant decrease (p less than 0.001) was noted in chronic lymphocytic leukemia lymphocytes that contained 1.4 +/- 0.3 mg actin/10(9) cells, constituting 4.3% +/- 1.1% of the total protein. Normal T and B cells did not differ in actin content. Reduced actin levels were found in the T as well as in the B lymphocytes of "B-cell" chronic lymphocytic leukemia. The possible importance of the decreased actin level in the anomalous capping response and motility of chronic lymphocytic leukemia lymphocytes is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6977383

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Fluorescent staining of the actin cytoskeleton in human lymphocytes, monocytes and polymorphonuclear cells using a DNAse 1/anti-DNAse 1 immunoglobulin fluorescein conjugated system.

Authors:  P J Philip; I Sudaka; B Mely-Goubert
Journal:  Histochemistry       Date:  1992

2.  Chaetoglobosin A preferentially induces apoptosis in chronic lymphocytic leukemia cells by targeting the cytoskeleton.

Authors:  P B Knudsen; B Hanna; S Ohl; L Sellner; T Zenz; H Döhner; S Stilgenbauer; T O Larsen; P Lichter; M Seiffert
Journal:  Leukemia       Date:  2013-11-27       Impact factor: 11.528

3.  Multicomponent analysis of amino acid transport in human lymphocytes. Diminished L-system transport in chronic leukemic B lymphocytes.

Authors:  G B Segel; W Simon; M A Lichtman
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

4.  Actin and tubulin of normal and leukaemic lymphocytes.

Authors:  H Atkins; P J Anderson
Journal:  Biochem J       Date:  1982-12-01       Impact factor: 3.857

5.  Changes in levels of actin and tubulin mRNAs upon the lectin activation of lymphocytes.

Authors:  E McCairns; D Fahey; G E Muscat; M Murray; P B Rowe
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

6.  The defect of lymphocyte locomotion in chronic lymphocytic leukaemia: studies of polarization and growth-dependent locomotion.

Authors:  P C Wilkinson; L N Islam; D Sinclair; J H Dagg
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

7.  Smooth muscle actin and s100p on non germinal centre diffuse large B cell lymphoma are adverse prognostic factors: pilot study.

Authors:  Howayda Abd El All
Journal:  Diagn Pathol       Date:  2007-03-02       Impact factor: 2.644

8.  Decreased deformability of lymphocytes in chronic lymphocytic leukemia.

Authors:  Yi Zheng; Jun Wen; John Nguyen; Mark A Cachia; Chen Wang; Yu Sun
Journal:  Sci Rep       Date:  2015-01-09       Impact factor: 4.379

Review 9.  Nanomechanics in Monitoring the Effectiveness of Drugs Targeting the Cancer Cell Cytoskeleton.

Authors:  Andrzej Kubiak; Tomasz Zieliński; Joanna Pabijan; Małgorzata Lekka
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.